(Q41501926)

1 October 2017

1 reference

title

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern? (English)

1 reference

1 October 2017

B J Lipworth

1

1 reference

1 October 2017

publication date

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

volume

16

1 reference

1 October 2017

issue

5

1 reference

1 October 2017

page(s)

295-308

1 reference

Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients

1 October 2017

cites work

1 reference

12 December 2020

Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship

1 reference

12 December 2020

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo

1 reference

12 December 2020

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment

1 reference

12 December 2020

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

12 December 2020

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

12 December 2020

In vitro desensitization of beta adrenergic receptors in human neutrophils. Attenuation by corticosteroids

1 reference

12 December 2020

Salmeterol xinafoate in children on high dose inhaled steroids

1 reference

12 December 2020

Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte beta 2-adrenoceptor function in asthmatic patients

1 reference

12 December 2020

A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group

1 reference

12 December 2020

Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma

1 reference

12 December 2020

Human lung cell beta 2-adrenergic receptors desensitize in response to in vivo administered beta-agonist

1 reference

12 December 2020

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

1 reference

12 December 2020

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

12 December 2020

1 reference

12 December 2020

Beta 2 adrenoceptor polymorphisms: are they clinically important?

1 reference

12 December 2020

Tolerance with beta 2-adrenoceptor agonists: time for reappraisal

1 reference

12 December 2020

Evaluation of partial beta-adrenoceptor agonist activity

1 reference

12 December 2020

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

1 reference

12 December 2020

Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine

1 reference

12 December 2020

Tolerance to the protective effect of salmeterol on allergen challenge

1 reference

12 December 2020

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

12 December 2020

Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen

1 reference

12 December 2020

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

12 December 2020

Hydrocortisone-induced reversal of beta-adrenergic receptor uncoupling

1 reference

12 December 2020

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

1 reference

12 December 2020

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

12 December 2020

Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids

1 reference

12 December 2020

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

1 reference

12 December 2020

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist

1 reference

12 December 2020

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

12 December 2020

Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness?

1 reference

12 December 2020

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

Functional antagonism: tolerance produced by inhaled beta 2 agonists

1 reference

12 December 2020

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

1 reference

12 December 2020

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

12 December 2020

Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids

1 reference

12 December 2020

The use of beta-agonists and the risk of death and near death from asthma

1 reference

12 December 2020

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients

1 reference

12 December 2020

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

12 December 2020

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

1 reference

12 December 2020

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

1 reference

12 December 2020

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

12 December 2020

Implications of genetic variability of human beta 2-adrenergic receptor structure

1 reference

12 December 2020

Effect of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilators

1 reference

12 December 2020

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group

1 reference

12 December 2020

Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma

1 reference

12 December 2020

Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.

1 reference

12 December 2020

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

12 December 2020

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

12 December 2020

Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma

1 reference

12 December 2020

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

1 reference

12 December 2020

10.2165/00002018-199716050-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

1 October 2017

1034261216

0 references

1 reference